Article

Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential.

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
Blood (impact factor: 9.9). 05/2009; 113(25):6342-50. DOI:10.1182/blood-2008-12-192054 pp.6342-50
Source: PubMed

ABSTRACT Hematopoietic stem cells (HSCs) are generally defined by their dual properties of pluripotency and extensive self-renewal capacity. However, a lack of experimental clarity as to what constitutes extensive self-renewal capacity coupled with an absence of methods to prospectively isolate long-term repopulating cells with defined self-renewal activities has made it difficult to identify the essential components of the self-renewal machinery and investigate their regulation. We now show that cells capable of repopulating irradiated congenic hosts for 4 months and producing clones of cells that can be serially transplanted are selectively and highly enriched in the CD150(+) subset of the EPCR(+)CD48(-)CD45(+) fraction of mouse fetal liver and adult bone marrow cells. In contrast, cells that repopulate primary hosts for the same period but show more limited self-renewal activity are enriched in the CD150(-) subset. Comparative transcriptome analyses of these 2 subsets with each other and with HSCs whose self-renewal activity has been rapidly extinguished in vitro revealed 3 new genes (VWF, Rhob, Pld3) whose elevated expression is a consistent and selective feature of the long-term repopulating cells with durable self-renewal capacity. These findings establish the identity of a phenotypically and molecularly distinct class of pluripotent hematopoietic cells with lifelong self-renewal capacity.

0 0
 · 
0 Bookmarks
 · 
39 Views
  • Source
    Article: Flow cytometry analysis of murine hematopoietic stem cells.
    [show abstract] [hide abstract]
    ABSTRACT: Hematopoietic stem cells (HSCs) remain the most well-characterized adult stem cell population both in terms of markers for purification and assays to assess functional potential. However, despite over 40 years of research, working with HSCs in the mouse remains challenging because of the relative abundance (or lack thereof) of these cells in the bone marrow. The frequency of HSCs in murine bone marrow is about 0.01% of total nucleated cells and ∼5,000 can be isolated from an individual mouse depending on the age, sex, and strain of mice as well as purification scheme utilized. Adding to the challenge is the continual reporting of new markers for HSC purification, which makes it difficult for the uninitiated in the field to know which purification strategies yield the highest proportion of long-term, multilineage HSCs. In this updated version of our review from 2009, we review different strategies for hematopoietic stem and progenitor cell identification and purification. We will also discuss methods for rapid flow cytometric analysis of peripheral blood cell types, and novel strategies for working with rare cell populations such as HSCs in the analysis of cell cycle status by BrdU, Ki-67, and Pyronin Y staining. The purpose of updating this review is to provide insight into some of the recent experimental and technical advances in mouse hematopoietic stem cell biology. © 2012 International Society for Advancement of Cytometry.
    Cytometry Part A 06/2012; · 3.73 Impact Factor
  • Source
    Article: Quantifying hematopoietic stem and progenitor cell mobilization.
    [show abstract] [hide abstract]
    ABSTRACT: Allogeneic donor blood cells and autologous peripheral blood leukocytes (PBL), obtained following -clinical mobilization procedures, are routinely used as a major source of hematopoietic stem and progenitor cells (HSPC) for transplantation protocols. It is, therefore, essential to evaluate and to quantify the extent by which the HSPC are mobilized and enriched in the circulation in correlation with their long-term hematopoietic reconstitution capacity. In this chapter, we describe quantitative methods that measure the number of mobilized HSPC according to specific criteria, as well as their functional properties in vitro and in vivo. The described assays are useful for assessment of progenitor cell mobilization as applied to both human and murine HSPC.
    Methods in molecular biology (Clifton, N.J.) 01/2012; 904:15-35.
  • Source
    Article: Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection?
    [show abstract] [hide abstract]
    ABSTRACT: Aging is associated with a marked increase in a number of diseases, including many types of cancer. Due to the complex and multi-factorial nature of both aging and cancer, accurate deciphering of causative links between aging and cancer remains a major challenge. It is generally accepted that initiation and progression of cancers are driven by a process of clonal evolution. In principle, this somatic evolution should follow the same Darwinian logic as evolutionary processes in populations in nature: diverse heritable types arising as a result of mutations are subjected to selection, resulting in expansion of the fittest clones. However, prevalent paradigms focus primarily on mutational aspects in linking aging and cancer. In this review, we will argue that age-related changes in selective pressures are likely to be equally important. We will focus on aging-related changes in the hematopoietic system, where age-associated alterations are relatively well studied, and discuss the impact of these changes on the development of leukemias and other malignancies.
    Aging 06/2011; 3(6):643-56. · 5.13 Impact Factor

Keywords

2 subsets
 
3 new genes
 
adult bone marrow cells
 
cells capable
 
Comparative transcriptome analyses
 
constitutes extensive self-renewal capacity
 
dual properties
 
elevated expression
 
extensive self-renewal capacity
 
Hematopoietic
 
HSCs
 
lifelong self-renewal capacity
 
long-term repopulating cells
 
mouse fetal liver
 
phenotypically
 
pluripotent hematopoietic cells
 
repopulate primary hosts
 
repopulating irradiated congenic hosts
 
selective feature
 
vitro